USPP35171P2 - Cannabis plant named ‘SW0’ - Google Patents
Cannabis plant named ‘SW0’ Download PDFInfo
- Publication number
- USPP35171P2 USPP35171P2 US17/300,819 US202117300819V USPP35171P2 US PP35171 P2 USPP35171 P2 US PP35171P2 US 202117300819 V US202117300819 V US 202117300819V US PP35171 P2 USPP35171 P2 US PP35171P2
- Authority
- US
- United States
- Prior art keywords
- variety
- superwoman
- thc
- new
- leaf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000218236 Cannabis Species 0.000 title claims abstract 3
- 241000196324 Embryophyta Species 0.000 description 17
- 244000025254 Cannabis sativa Species 0.000 description 8
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 8
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 8
- 229960004242 dronabinol Drugs 0.000 description 8
- 240000004308 marijuana Species 0.000 description 7
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 6
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 229950011318 cannabidiol Drugs 0.000 description 5
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 5
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 5
- 229930003827 cannabinoid Natural products 0.000 description 4
- 239000003557 cannabinoid Substances 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 108091030071 RNAI Proteins 0.000 description 3
- 230000011681 asexual reproduction Effects 0.000 description 3
- 238000013465 asexual reproduction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000002621 endocannabinoid Substances 0.000 description 3
- 230000009368 gene silencing by RNA Effects 0.000 description 3
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
- 150000001200 N-acyl ethanolamides Chemical class 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 229940065144 cannabinoids Drugs 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000011487 hemp Substances 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 101000712615 Cannabis sativa Tetrahydrocannabinolic acid synthase Proteins 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241001232566 Chamaeleo sp. Species 0.000 description 1
- 241000006479 Cyme Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000255540 Drosophila stigma Species 0.000 description 1
- 241000221785 Erysiphales Species 0.000 description 1
- 229940124602 FDA-approved drug Drugs 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- 241001075561 Fioria Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 240000002393 Murraya koenigii Species 0.000 description 1
- 244000090896 Nigella sativa Species 0.000 description 1
- 101100268917 Oryctolagus cuniculus ACOX2 gene Proteins 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000008154 Piper betle Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 244000007021 Prunus avium Species 0.000 description 1
- 235000010401 Prunus avium Nutrition 0.000 description 1
- 241000146173 Solanum giganteum Species 0.000 description 1
- UCONUSSAWGCZMV-UHFFFAOYSA-N Tetrahydro-cannabinol-carbonsaeure Natural products O1C(C)(C)C2CCC(C)=CC2C2=C1C=C(CCCCC)C(C(O)=O)=C2O UCONUSSAWGCZMV-UHFFFAOYSA-N 0.000 description 1
- 241001454295 Tetranychidae Species 0.000 description 1
- 240000009239 Tulbaghia violacea Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- -1 clothing Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000022602 disease susceptibility Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000010196 hermaphroditism Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229940023569 palmate Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
Images
Definitions
- the new Cannabis plant claimed is of the variety denominated ‘SW0’.
- the present invention relates to a new and distinct annual variety of C. sativa , which has been given the variety denomination of ‘SW0’.
- SW0’ is intended for use as for sale in Cannabis dispensaries and to make products containing no THC.
- the genus Cannabis has been in use by humans for millennia, due to the multiplicity of its benefits to humans, including the considerable value and utility of its fiber, the nutritional value of its seeds, and the medicinal value of its floral parts and products made from them.
- the genus is under intense legal commercialization in the United States as industrial hemp for a variety of purposes including biodegradable plastics and building materials, clothing, paper, food, fuel, and medicines.
- CBD Cannabidiol extracted from Cannabis is widely used in over-the-counter medicines and topical treatments and is also the active ingredient in the FDA-approved drug Epidiolex.
- CBD is just one of at least dozens—perhaps hundreds—of cannabinoids endogenous to Cannabis , tetrahydrocannabinol (THC) being the other cannabinoid that is most well-known.
- THC tetrahydrocannabinol
- the cannabinoids as a group interact with the human endocannabinoid receptors, which are distributed in the brain and throughout the body.
- ECS endocannabinoid system
- marijuana products are available to users for purchase in specialized “dispensaries” that offer dried flower, edibles, tinctures, extracts, and the like.
- a unique or unusual chemical profile, or chemotype is attractive not only for flower sales but also for use in the preparation of extracts and/or isolates and for the manufacture of a variety of products that possess characteristics of the chemotype.
- the present invention relates to a new and distinct annual variety of C. sativa , which has been given the variety denomination of ‘SW0’.
- the new C. sativa variety is a selection resulting from conventional breeding as shown in FIG. 1 , followed by genetic modification.
- C. sativa varieties known as ‘Cherry Wine’ (unpatented) and ‘The Wife’ (unpatented) were reciprocally crossed, such that each variety was the seed parent in one cross and the pollen parent in a different cross. Segregating progeny of the reciprocal crosses were selected based upon the phenotypic traits described herein, and particularly those by which the variety ‘Super woman’ differs from ‘Cherry Wine’ and ‘The Wife’.
- a pollen parent was selected from the cross in which ‘The Wife’ was the prior pollen parent, and various seed parents were selected from the cross in which ‘The Wife’ was the prior seed parent. These seed parents were crossed with the pollen parent, as shown in FIG. 1 .
- offspring from the second step were selected based upon phenotypic characteristics described hereof, and the final selection was designated ‘Super woman’.
- ‘Super woman’ which is distinguishable from both ‘Cherry Wine’ and ‘The Wife’ as described hereof was then modified using guided RNAi to create a THC-null variant, designated ‘SW0’, showing reduced expression of THCA synthase.
- This new variety ‘SW0’ is substantially indistinguishable in all respects from ‘Super woman’ except that ‘SW0’ is THC-null (meaning no THC is produced in the flower), due to the action of the RNAi construct.
- ‘Super woman’ selection was subsequently evaluated for a number of years at Colorado, USA. ‘SW0’ was selected to be as nearly identical to ‘Super woman’ as was attainable. ‘SW0’ looks the same as ‘Super woman’ and further propagation via cloning and meristem tissue culture has shown the same characteristics: the two varieties are meaningfully distinguishable only on the basis of their accumulation of THCA and other forms of THC.
- the new C. sativa variety is THC-null.
- Plants of the new variety differ from plants of the related variety ‘Cherry Wine’ (not patented) primarily in tighter internodal spacing, shorter plants, more balanced hybrid, and more balanced CBD ratio. Plants of the new variety differ from plants of the related variety ‘The Wife’ (not patented) primarily in displaying great resiliency to mold and pathogens, better yields, more vigor, and being more versatile in different growing environments. Plants of the new variety ‘SW0’ differ from ‘Super woman’ (not patented) in having little to no THC % present in mature flowers, while ‘Super woman’ has THC levels that exceed the federal 0.3% threshold.
- FIG. 1 is a diagram of the breeding history of the ‘Super woman’ and the new variety ‘SW0’.
- FIG. 2 is a photograph of the flower of a mature ‘SW0’ plant.
- FIG. 3 is a photograph of the whole plant of ‘SW0’ at 7-8 weeks of age coming out of in-vitro transplant shock to soil.
- FIG. 4 is a photograph that shows the early stages of a flowering plant of ‘SW0’.
- FIG. 5 is a photograph of a healthy ‘SW0’ plant before going into the flower stage.
- FIG. 6 is a photograph of the cuttings of a plant of ‘SW0’.
- FIG. 7 is a photograph that shows the 5th week of flower of a mature plant of ‘SW0’.
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The unique annual herbaceous Cannabis plant variety ‘SW0’ is provided. The variety can be distinguished by its outstanding features.
Description
Latin name of the genus and species:
Genus—Cannabis.
Species—sativa.
Variety denomination: The new Cannabis plant claimed is of the variety denominated ‘SW0’.
None.
The present invention relates to a new and distinct annual variety of C. sativa, which has been given the variety denomination of ‘SW0’. ‘SW0’ is intended for use as for sale in Cannabis dispensaries and to make products containing no THC.
The genus Cannabis has been in use by humans for millennia, due to the multiplicity of its benefits to humans, including the considerable value and utility of its fiber, the nutritional value of its seeds, and the medicinal value of its floral parts and products made from them. Currently the genus is under intense legal commercialization in the United States as industrial hemp for a variety of purposes including biodegradable plastics and building materials, clothing, paper, food, fuel, and medicines.
Cannabidiol (CBD) extracted from Cannabis is widely used in over-the-counter medicines and topical treatments and is also the active ingredient in the FDA-approved drug Epidiolex. CBD is just one of at least dozens—perhaps hundreds—of cannabinoids endogenous to Cannabis, tetrahydrocannabinol (THC) being the other cannabinoid that is most well-known. The cannabinoids as a group interact with the human endocannabinoid receptors, which are distributed in the brain and throughout the body. The study of the endocannabinoid system (ECS) in humans and other mammals is an area of increasing interest and holds tremendous promise for the future of medicine. See, e.g., Russo (2019). Cannabis and Pain, Pain Medicine, 20(10): 1093/pm/pnz227; and Russo (2016). Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes, Cannabis Cannabinoid Res. 1(1): 154-165.
Typically, marijuana products are available to users for purchase in specialized “dispensaries” that offer dried flower, edibles, tinctures, extracts, and the like. In some cases, a unique or unusual chemical profile, or chemotype, is attractive not only for flower sales but also for use in the preparation of extracts and/or isolates and for the manufacture of a variety of products that possess characteristics of the chemotype.
The present invention relates to a new and distinct annual variety of C. sativa, which has been given the variety denomination of ‘SW0’.
The new C. sativa variety is a selection resulting from conventional breeding as shown in FIG. 1 , followed by genetic modification. At the first step of this breeding, C. sativa varieties known as ‘Cherry Wine’ (unpatented) and ‘The Wife’ (unpatented), were reciprocally crossed, such that each variety was the seed parent in one cross and the pollen parent in a different cross. Segregating progeny of the reciprocal crosses were selected based upon the phenotypic traits described herein, and particularly those by which the variety ‘Superwoman’ differs from ‘Cherry Wine’ and ‘The Wife’. At the second step of the breeding, a pollen parent was selected from the cross in which ‘The Wife’ was the prior pollen parent, and various seed parents were selected from the cross in which ‘The Wife’ was the prior seed parent. These seed parents were crossed with the pollen parent, as shown in FIG. 1 . In the third step of breeding, offspring from the second step were selected based upon phenotypic characteristics described hereof, and the final selection was designated ‘Superwoman’. ‘Superwoman’, which is distinguishable from both ‘Cherry Wine’ and ‘The Wife’ as described hereof was then modified using guided RNAi to create a THC-null variant, designated ‘SW0’, showing reduced expression of THCA synthase. This new variety ‘SW0’ is substantially indistinguishable in all respects from ‘Superwoman’ except that ‘SW0’ is THC-null (meaning no THC is produced in the flower), due to the action of the RNAi construct.
The ‘Superwoman’ selection was subsequently evaluated for a number of years at Colorado, USA. ‘SW0’ was selected to be as nearly identical to ‘Superwoman’ as was attainable. ‘SW0’ looks the same as ‘Superwoman’ and further propagation via cloning and meristem tissue culture has shown the same characteristics: the two varieties are meaningfully distinguishable only on the basis of their accumulation of THCA and other forms of THC.
Asexual reproduction of ‘Superwoman’ by cutting propagation since 2017 at Colorado, USA has demonstrated that it reproduces true to type with all of the characteristics, as herein described, firmly fixed and retained through successive generations of such asexual propagation. Further, asexual reproduction of ‘SW0’ at Longmont, Colo., conducted in 2021 and 2022, using vegetative cloning and tissue culture has shown essentially identical behavior. A stable seed line of ‘Superwoman’ was developed by successive generations of interbreeding and selection to correspond to the phenotypic characteristics described herein.
The following characteristics of the new variety have been repeatedly observed and can be used to distinguish ‘SW0’ as a new and distinct variety of C. sativa plant: the new C. sativa variety is THC-null.
Plants of the new variety differ from plants of the related variety ‘Cherry Wine’ (not patented) primarily in tighter internodal spacing, shorter plants, more balanced hybrid, and more balanced CBD ratio. Plants of the new variety differ from plants of the related variety ‘The Wife’ (not patented) primarily in displaying great resiliency to mold and pathogens, better yields, more vigor, and being more versatile in different growing environments. Plants of the new variety ‘SW0’ differ from ‘Superwoman’ (not patented) in having little to no THC % present in mature flowers, while ‘Superwoman’ has THC levels that exceed the federal 0.3% threshold.
The accompanying photographic illustrations show the typical appearance of the new variety ‘SW0’. The colors are as nearly true as is reasonably possible in a color representation of this type. Colors in the photographs may differ slightly from the color values cited in the detailed botanical description which accurately describes the colors of the new plant.
The following detailed description sets forth the distinctive characteristics of ‘SW0’. The data which define these characteristics were collected from asexual reproductions of the original selection, ‘Superwoman’ which is identical to ‘SW0’ in all respects except the RNAi construct and the resulting THC-null phenotype. The purpose of this new variety ‘SW0’ is not a morphological distinction from ‘Superwoman’ but is a chemovar with no THC. Dimensions, sizes, colors, and other characteristics are approximations and averages set forth as accurately as possible. The descriptions relate to plants grown in Colorado, USA. Color notations are in reference to the standard RGB color chart known to those of ordinary skill in internet website design. Color coordinates were derived using a digital device. In some cases, there is no standard corresponding color name so only the RGB coordinates are provided.
- Type: Herbaceous tap-rooted annual.
- Classification:
-
- a. Family.—Cannabaceae.
- b. Genus.—Cannabis.
- c. Species.—sativa.
- d. Common name.—Hemp.
-
- Parentage: As depicted in
FIG. 1 : original parents ‘Cherry Wine’ x ‘The Wife’ in reciprocal crosses, followed by sibling crosses and selection to produce ‘Superwoman’ which was genetically modified to create a THC-null phenotype, designated as ‘SW0’. - Market class: Medicinal herb for CBD extraction.
- General:
-
- a. Origin.—Longmont, Colo.
- b. Parentage.—i. Male parent — 1%. ii. Female parent — 99%.
- c. Average height.—6-10 feet.
- d. Average spread.—4-5 feet.
- e. Growth rate.—Vigorous.
- f. Flower storage life.—Up to 2 years.
- g. Productivity.—Up to 5 lbs.
- h. Disease resistance/susceptibility.—Resistance to powdery mildew, mold.
- i. Pest resistance/susceptibility.—Resistance to spider mites.
- j. Fragrance.—A cheesy funk of sweet cherries and garlic pepper.
- k. Proportion of hermaphrodite plants.—Low.
- l. Proportion of female plants.—High.
- m. Proportion of male plants.—Low.
- n. Type of inflorescence.—Racemose.
- o. Photoperiodicity.—18 weeks.
- p. Number of flowers per cyme.—5-7.
- q. Pollen description.—Medium size pollen sacks.
-
- General:
-
- a. Average diameter.—2-5 inches.
- b. Shape.—Long, round, and thick.
- c. Average length of internode.—3-5 inches.
- d. Depth of grooves.—Medium.
- e. Pith in cross section.—Medium.
- f. Trichome type.—Capitate stalked.
- g. Color.—Green (RGB: 83, 74, 62).
-
- General:
-
- a. Quantity.—High.
- b. Leaf color.—Green (RGB 92, 93, 62).
- c. Leaf arrangement.—5 point tip fan leaf.
- d. Leaf shape.—Palmate shape.
- e. Leaf margins.—Serrate.
- f. Undulation of margin.—No undulation.
- g. Leaf apex shape.—Sharp.
- h. Leaf base shape.—Rounded.
- i. Average leaf width.—5 inches.
- j. Average leaf length.—9 to 10 inches.
- k. Number of leaflets per leaf.—5 to 7.
- l. Central leaflet length.—9 to 10 inches.
- m. Central leaflet width.—1.5 to 2 inches.
- n. Number of teeth in the middle of leaflet.—22 teeth.
- o. Margin type.—Pointy/sharp.
- p. Trichome type (top surface).—Capitate stalked on sugar leaves.
- q. Trichome type (bottom surface).—Capitate stalked.
- r. Texture of top and bottom surfaces.—Smooth with small ridges on the bottom.
- s. Venation type.—Pinnately parallel venation.
-
- General:
-
- a. Length.—4 to 5 cm on fan leaves.
- b. Surface texture.—Smooth.
- c. Anthocyanin intensity.—Very low.
-
- General:
-
- a. Natural flowering season.—Second week of August.
- b. Average size.—1.5 cm per pistil cluster.
- c. Quantity per inflorescence.—10-14 on apical inflorescence.
- d. General description of calyx.—Thick with hairs on end of flower.
- e. General description of cola.—Thick and dense covered in trichomes.
- f. General description of node.—Multiple levels throughout the plant.
- g. Bract.—i. Size — 0.6 cm. ii. Quantity — 9 to 12. iii. Shape — Almonds/tear shaped. iv. Trichome type — Capitate stalked. v. Case — None. vi. Texture — Soft and sticky.
- h. Bracteole.—i. Size — 0.6 cm. ii. Quantity — 2 per bract. iii. Shape — Half drop. iv. Trichome type — Capitate stalked.
- i. Stigma.—i. Size — 1 inch. ii. Quantity — Dense. iii. Shape — Stringy, long and curly. iv. Trichome type — Capitate stalked.
- j. Stipule.—i. Size — ¼ inch. ii. Quantity —2 per internode. iii. Shape — Almond with pointy end. iv. Trichome type — Capitate stalked.
- k. Ovary.—i. Position — Central. ii. Shape — Oval. iii. Length —1 mm.
-
- General:
-
- a. Shape.—Oval and uniform shape.
- b. Length.—3.1 mm.
- c. Width.—2.3 mm.
- d. Weight per 1000 seeds.—13 grams.
- e. Marbling.—Strong.
- f. Marbling length.—1.5-2 mm.
- g. Cotyledon measurements.—5 mm.
-
Claims (1)
1. A new and distinct variety of Cannabis plant named ‘SW0’, as illustrated and described herein.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/300,819 USPP35171P2 (en) | 2021-11-17 | 2021-11-17 | Cannabis plant named ‘SW0’ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/300,819 USPP35171P2 (en) | 2021-11-17 | 2021-11-17 | Cannabis plant named ‘SW0’ |
Publications (2)
Publication Number | Publication Date |
---|---|
USPP35171P2 true USPP35171P2 (en) | 2023-05-16 |
US20230157190P1 US20230157190P1 (en) | 2023-05-18 |
Family
ID=86323540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/300,819 Active USPP35171P2 (en) | 2021-11-17 | 2021-11-17 | Cannabis plant named ‘SW0’ |
Country Status (1)
Country | Link |
---|---|
US (1) | USPP35171P2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230337560P1 (en) * | 2019-12-12 | 2023-10-19 | David Straub | Cannabis plant named 'ow-1' |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USPP32318P3 (en) * | 2018-04-10 | 2020-10-13 | Aurora Cannabis Enterprises Inc. | Cannabis plant named ‘MR2017002’ |
USPP32725P2 (en) * | 2019-10-22 | 2021-01-05 | Biomax Seeds S.L. | Cannabis plant named ‘PAN2020’ |
-
2021
- 2021-11-17 US US17/300,819 patent/USPP35171P2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USPP32318P3 (en) * | 2018-04-10 | 2020-10-13 | Aurora Cannabis Enterprises Inc. | Cannabis plant named ‘MR2017002’ |
USPP32725P2 (en) * | 2019-10-22 | 2021-01-05 | Biomax Seeds S.L. | Cannabis plant named ‘PAN2020’ |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230337560P1 (en) * | 2019-12-12 | 2023-10-19 | David Straub | Cannabis plant named 'ow-1' |
USPP36496P3 (en) * | 2019-12-12 | 2025-02-25 | David Straub | Cannabis plant named ‘ow-1’ |
Also Published As
Publication number | Publication date |
---|---|
US20230157190P1 (en) | 2023-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USPP35171P2 (en) | Cannabis plant named ‘SW0’ | |
US20100218290P1 (en) | Southern highbush blueberry plant named 'th-682' | |
US20220159921A1 (en) | Cannabis plant named 'drg3' | |
US11330778B2 (en) | Cannabis plant named ‘FS-tp2’ | |
USPP33162P3 (en) | Hemp plant named ‘Eighty Eight’ | |
US20240008379P1 (en) | Cannabis plant named '21af0716' | |
USPP33182P3 (en) | Hemp plant named ‘Painted Lady’ | |
US20240306521P1 (en) | Cannabis plant named 'rsbt1brm' | |
USPP34829P3 (en) | Cannabis plant named BAGZXCD6-PA#2 | |
USPP31354P3 (en) | Artichoke plant named ‘PS-MSG0677’ | |
USPP35836P3 (en) | Cannabis plant named ‘OT-1’ | |
USPP36496P3 (en) | Cannabis plant named ‘ow-1’ | |
US20220256799A1 (en) | Cannabis plant named 'lpa004' | |
USPP28004P3 (en) | Echeveria plant named ‘COLORSHIFT’ | |
US20230329130P1 (en) | Cannabis Plant Named 'DRG2' | |
USPP35477P2 (en) | Nelumbo plant named ‘QINHUAI CHENWU’ | |
USPP17976P2 (en) | Sweetpotato plant named ‘Stokes purple’ | |
USPP33828P2 (en) | Begonia plant named ‘BKPBEBO’ | |
USPP34901P2 (en) | Shrub rose plant named ‘Royal Sunrise’ | |
US20230301221P1 (en) | Cannabis plant named 'DRG3' | |
US20230157189P1 (en) | Apple Tree Rootstock Named 'D2212' | |
USPP31010P2 (en) | Grapevine plant named ‘JB06-43-6-22’ | |
USPP32719P2 (en) | Mango tree named ‘Magriver’ | |
USPP29787P3 (en) | Blueberry plant named ‘Echo’ | |
USPP21284P3 (en) | Hybrid Tea rose plant named ‘Meibidull’ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |